ES2046889T3 - Metodo para inhibicion de la maduracion folicular. - Google Patents

Metodo para inhibicion de la maduracion folicular.

Info

Publication number
ES2046889T3
ES2046889T3 ES199191902826T ES91902826T ES2046889T3 ES 2046889 T3 ES2046889 T3 ES 2046889T3 ES 199191902826 T ES199191902826 T ES 199191902826T ES 91902826 T ES91902826 T ES 91902826T ES 2046889 T3 ES2046889 T3 ES 2046889T3
Authority
ES
Spain
Prior art keywords
maturation
folicular
inhibition
ovary
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES199191902826T
Other languages
English (en)
Inventor
Teresa K. Woodruff
Jennie P. Mather
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ES2046889T3 publication Critical patent/ES2046889T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE PRESENTA UN METODO PARA INHIBIR LA MADURACION DE LOS FOLICULOS EN EL OVARIO DE UN MAMIFERO HEMBRA; EL METODO COMPRENDE LA ADMINISTRACION AL OVARIO DEL MAMIFERO DE UNA CANTIDAD EFECTIVA DE ACTIVINA. ESTE METODO ES PARTICULARMENTE EFECTIVO PARA EL TRATAMIENTO DE LA ENFERMEDAD POLICISTICA DEL OVARIO.
ES199191902826T 1990-01-08 1991-01-04 Metodo para inhibicion de la maduracion folicular. Expired - Lifetime ES2046889T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/461,705 US5102868A (en) 1990-01-08 1990-01-08 Method for inhibiting follicular maturation

Publications (1)

Publication Number Publication Date
ES2046889T3 true ES2046889T3 (es) 1994-02-01

Family

ID=23833619

Family Applications (1)

Application Number Title Priority Date Filing Date
ES199191902826T Expired - Lifetime ES2046889T3 (es) 1990-01-08 1991-01-04 Metodo para inhibicion de la maduracion folicular.

Country Status (10)

Country Link
US (1) US5102868A (es)
EP (1) EP0509047B1 (es)
JP (1) JPH05503702A (es)
AT (1) ATE94405T1 (es)
AU (1) AU636195B2 (es)
CA (1) CA2069756A1 (es)
DE (1) DE69100376T2 (es)
DK (1) DK0509047T3 (es)
ES (1) ES2046889T3 (es)
WO (1) WO1991010446A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489288B1 (en) 1990-03-16 2002-12-03 Applied Research Systems Ars Holding Treatment of polycystic ovarian disease
WO1992004913A1 (en) * 1990-09-13 1992-04-02 Children's Hospital Medical Center Of Northern California Method for increasing red blood cell production by treatment with activin or activin-related peptides
US5563059A (en) * 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
US5487895A (en) * 1993-08-13 1996-01-30 Vitaphore Corporation Method for forming controlled release polymeric substrate
WO1995005161A1 (en) * 1993-08-13 1995-02-23 Vitaphore Corporation Hydrogel-based microsphere drug delivery systems
US5545616A (en) * 1994-09-22 1996-08-13 Genentech, Inc. Method for predicting and/or preventing preterm labor
GB2306481A (en) * 1995-10-21 1997-05-07 Univ Manchester Pharmaceutical comprising a stimulator of activin and/or inhibin
AUPO638897A0 (en) * 1997-04-23 1997-05-22 Monash University Modulation of cell growth and methods relating thereto
JP2003516746A (ja) * 1999-12-15 2003-05-20 リサーチ ディベロップメント ファンデーション インヒビン・レセプタとしてのベータグリカン及びその利用法
US20030144203A1 (en) * 2001-12-19 2003-07-31 Voyager Pharmaceutical Corporation Methods for slowing senescence and treating and preventing diseases associated with senescence
EP1776131A1 (en) * 2004-08-10 2007-04-25 Voyager Pharmaceutical Corporation Methods for treating premature infants
US20060234274A1 (en) * 2005-03-29 2006-10-19 Auckland Uniservices Limited Methods of diagnosis
US7954505B2 (en) * 2007-12-03 2011-06-07 Matthew Odachowski Mobile leakage containment box including a liquid impermeable membrane
CN116948028B (zh) * 2023-09-20 2023-11-28 北京合源汇丰医药科技有限公司 一种抗抑制素抗体及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764502A (en) * 1983-03-15 1988-08-16 University Of Southern California Intragonadal regulatory protein
US4734398A (en) * 1983-03-15 1988-03-29 University Of Southern California Follicular regulating protein
US4912201A (en) * 1983-03-15 1990-03-27 University Of Southern California Monoclonal antibodies and antisera to intragonadal regulatory protein
CA1268417A (en) * 1984-10-11 1990-05-01 Gere S. Dizerega Intragonadal regulatory protein
US4798885A (en) * 1986-02-07 1989-01-17 Genentech, Inc. Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
US4864019A (en) * 1985-11-08 1989-09-05 The Salk Institute For Biological Studies Antibodies to inhibin and conjugates produced therefrom
US4997815A (en) * 1988-11-01 1991-03-05 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin
US5166190A (en) * 1990-01-08 1992-11-24 Genentech, Inc. Method for increasing fertility in males

Also Published As

Publication number Publication date
JPH05503702A (ja) 1993-06-17
US5102868A (en) 1992-04-07
DE69100376D1 (de) 1993-10-21
CA2069756A1 (en) 1991-07-09
ATE94405T1 (de) 1993-10-15
AU636195B2 (en) 1993-04-22
DK0509047T3 (da) 1994-03-21
EP0509047B1 (en) 1993-09-15
EP0509047A1 (en) 1992-10-21
DE69100376T2 (de) 1994-03-17
AU7078391A (en) 1991-08-05
WO1991010446A1 (en) 1991-07-25

Similar Documents

Publication Publication Date Title
ES2046889T3 (es) Metodo para inhibicion de la maduracion folicular.
DK0665013T3 (da) Behandling af hyperproliferative karsygdomme
BR9809115A (pt) Métodos para tratar inflamação e doenças inflamatórias usando inibidores de padprt
PT97950A (pt) Processo para a preparacao de derivados de acidos 3-aril-2-hidroxipropionicos e de analogos que sao agentes hipoglicemicos
SE8300718L (sv) Metod och komposition for behandling av akne
BR9106938A (pt) Terapia de beta-caroteno e vitamina e para inibicao de ocorrencias vasculares maiores
GR3024421T3 (en) Benzenesulfonamide derivative
DE69229598T2 (de) Verfahren zur vorbeugung nmda-rezeptorkomplex-vermittelter neuronaler schäden
FI944339A0 (fi) Ihon rasvaisuutta säätelevä aine
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
NO920843L (no) Fremgangsmaate ved behandling av en underjordisk formasjon
ES2055406T3 (es) Composicion para el tratamiento de la inflamacion.
ES2059121T3 (es) Uso de agentes sensibilizantes de insulina para tratar la hipertension.
MX9401294A (es) Derivados de azolona sustituida
BR9005602A (pt) Processo para tratamento de componente ferroso para subsequente ligacao com aluminio fundido
BR9706966A (pt) Utilização do enanciômero-l de um composto e processo para tratamento ou profilaxia de câncer da mama
BR9100519A (pt) Composto,composicao farmaceutica,metodo para inibicao de colinesterase em um mamifero e metodo para melhorar a memoria ou tratar ou prevenir a doenca de alzheimer
BR9606528A (pt) Composto sal de um composto processo para a preparação de um composto composição farmacêutica produto uso de um composto e método para o tratmento de um mamífero que necessita de um agente antineoplásico
HU891056D0 (en) Process for treating the diseases of the gullet and the stomach-intestine system
PT95456A (pt) Processo para a preparacao de preparados de combinacao de acido acetilsalicilico e de derivados de carbaciclina com accao antitrombotica
DK0509040T3 (da) Fremgangsmåde til forøgelse af fertiliteten hos hunkønsvæsener
BR9306899A (pt) Processo e composto de derivados de quinoliniloxadiazola composição herbicida e método para usar derivados de quinoliniloxadiazola
PT99380A (pt) Processo para a preparacao de uma composicao anti-tussica para seres humanos que compreende dextrometorfano
BR9307121A (pt) Ferramenta para o tratamento de superfícies de componentes
EP0759781A4 (en) METHOD FOR TREATING AND PREVENTING ATHEROSCLEROSIS

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 509047

Country of ref document: ES